相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
Simon A. Joosse et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Preclinical mouse models for BRCA1-associated breast cancer
R. M. Drost et al.
BRITISH JOURNAL OF CANCER (2009)
High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer
Henne Holstege et al.
CANCER RESEARCH (2009)
High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
Elodie Manie et al.
CANCER RESEARCH (2009)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
From Human to Mouse and Back: Tumorgraft Models Surge in Popularity
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
A Selective Requirement for 53BP1 in the Biological Response to Genomic Instability Induced by Brca1 Deficiency
Liu Cao et al.
MOLECULAR CELL (2009)
Validated germline-competent embryonic stem cell lines from nonobese diabetic mice
Jennifer Nichols et al.
NATURE MEDICINE (2009)
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim et al.
NATURE MEDICINE (2009)
Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer
Fleur Huang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice
Min Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Julian Puppe et al.
BREAST CANCER RESEARCH (2009)
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors
Norazizah Shafee et al.
CANCER RESEARCH (2008)
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
Elizabeth M. Swisher et al.
CANCER RESEARCH (2008)
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin
Bastiaan Evers et al.
CLINICAL CANCER RESEARCH (2008)
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer
Angela Chetrit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
The ground state of embryonic stem cell self-renewal
Qi-Long Ying et al.
NATURE (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Lao H. Saal et al.
NATURE GENETICS (2008)
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
Alexandra M. Pietersen et al.
BREAST CANCER RESEARCH (2008)
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes
Douglas F. Easton et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
A mouse model of basal-like breast carcinoma with metaplastic elements
A. McCarthy et al.
JOURNAL OF PATHOLOGY (2007)
BRCA1 dysfunction in sporadic basal-like breast cancer
N. C. Turner et al.
ONCOGENE (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Founder mutations in BRCA1 and BRCA2 genes
R. Ferla et al.
ANNALS OF ONCOLOGY (2007)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B. Evers et al.
ONCOGENE (2006)
The role of BRCA1 in transcriptional regulation and cell cycle control
P. B. Mullan et al.
ONCOGENE (2006)
Model organisms - The mighty mouse: genetically engineered mouse models in cancer drug development
Norman E. Sharpless et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Prevention and management of hereditary breast cancer
SA Narod et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BRCA1 supports XIST RNA concentration on the inactive X chromosome
S Ganesan et al.
CELL (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
XL Xu et al.
NATURE GENETICS (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
